Epidermal growth factor receptor inhibitor AG1478 affects HepG2 cell proliferation, cell cycle, apoptosis and c-Myc protein expression in a dose-dependent manner

摘要

The aim of this study was to observe the effect of AG1478, an inhibitor of the epidermal growth factor receptor, on cell proliferation, cell cycle and apoptosis of human hepatoma HepG2 cells. Cell counting kit-8 assay was employed to examine the survival rates of cultured HepG2 cells after treatments with different concentrations of AG1478 for 24?h. Flow cytometry was performed to determine the effect of AG1478 on cell cycle and apoptosis. Immunohistochemistry was used to measure the expression of c-Myc protein. The survival rates of human hepatoma HepG2 cells after treatments with 5, 10, 20 and 40 μmol/L of AG1478 for 24?h were 76.0%, 59.6%, 51.2% and 42.1%, respectively. The apoptotic rates after treatments with 5, 10, 20 and 40 μmol/L of AG1478 were (12.88?±?1.91)%, (23.16?±?2.67)%, (35.36?±?1.95)% and (47.16?±?3.78)%, respectively. HepG2 cells were mainly arrested in the G0/G1 phase after treatment with 10, 20 and 40 μmol/L of AG1478. The c-Myc protein was highly expressed in HepG2 cells, whereas treatment with 20 μmol/L AG1478 substantially inhibited its expression. Overall, AG1478 inhibited the proliferation of human hepatoma cells in vitro , arrested the cells in G0/G1 phase, induced apoptosis and reduced the expression of c-Myc protein. These results also indicated that AG1478 blocked the proliferation and induced apoptosis of hepatoma cells in a dose-dependent manner.